United States Pharmaceuticals

Integrated Biopharma Inc (INBP)

Track

Track

Integrated Biopharma Inc has recorded no insider trading activity within the last three months. Historical data indicates the most recent transaction occurred on June 27, 2012, involving a sale by the CEO. Previous years featured various buying and selling patterns among executives, though these events remain dated.
Ticker: INBP Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
KAY E GERALD CEO AND PRESIDENT Executive Director Large shareholder
Transaction date
Sale
Price
447.09
Quantity 48,355 -28.0%
Value US$1,478,121
DESANTIS CARL Non-Executive Director Large shareholder
Transaction date
Purchase
Price
308.45
Quantity 92,430 +11.4%
Value US$3,159,408
KAY E GERALD Chairman and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
323.84
Quantity 14,953 -0.1%
Value US$3,195,063
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
6.93
Quantity 600 -1.0%
Value US$4,155
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
6.90
Quantity 900 -1.4%
Value US$6,210
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
6.90
Quantity 1,000 -1.5%
Value US$6,900
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
7.00
Quantity 500 -0.8%
Value US$3,500
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
6.85
Quantity 3,000 -4.2%
Value US$20,550
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
7.00
Quantity 500 -0.7%
Value US$3,500
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
12.80
Quantity 2,200 -3.0%
Value US$28,160
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
12.87
Quantity 500 -0.7%
Value US$6,435
FRIEDMAN ERIC J Chief Financial Officer Officer
Transaction date
Sale
Price
12.90
Quantity 300 -0.4%
Value US$3,870
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-06-29 2012-06-27 S Sale KAY E GERALD

CEO AND PRESIDENT

Executive Director Large shareholder
48,355 -28.0%
447.09
US$1,478,121 		48,355 -28.0% 447.09 US$1,478,121
2009-10-28 2009-04-06 B Purchase DESANTIS CARL Non-Executive Director Large shareholder
92,430 +11.4%
308.45
US$3,159,408 		92,430 +11.4% 308.45 US$3,159,408
2005-03-24 2005-03-22 B Purchase KAY E GERALD

Chairman and CEO

Executive Director Large shareholder
14,953 -0.1%
323.84
US$3,195,063 		14,953 -0.1% 323.84 US$3,195,063
2005-01-14 2005-01-12 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
600 -1.0%
6.93
US$4,155 		600 -1.0% 6.93 US$4,155
2005-01-12 2005-01-11 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
900 -1.4%
6.90
US$6,210 		900 -1.4% 6.90 US$6,210
2005-01-12 2005-01-11 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
1,000 -1.5%
6.90
US$6,900 		1,000 -1.5% 6.90 US$6,900
2005-01-12 2005-01-10 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
500 -0.8%
7.00
US$3,500 		500 -0.8% 7.00 US$3,500
2005-01-11 2005-01-07 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
3,000 -4.2%
6.85
US$20,550 		3,000 -4.2% 6.85 US$20,550
2005-01-11 2005-01-07 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
500 -0.7%
7.00
US$3,500 		500 -0.7% 7.00 US$3,500
2004-01-09 2004-01-08 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
2,200 -3.0%
12.80
US$28,160 		2,200 -3.0% 12.80 US$28,160
2004-01-09 2004-01-08 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
500 -0.7%
12.87
US$6,435 		500 -0.7% 12.87 US$6,435
2004-01-09 2004-01-08 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
300 -0.4%
12.90
US$3,870 		300 -0.4% 12.90 US$3,870
Explore more

More insider trading research around Integrated Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America